McMaster University

 

Search

Explore



Dr. Ronald Barr
Dr. Ronald Barr

Cancer in childhood is
curable - but at what cost?

While cancer remains the commonest cause of disease-related death in children and adolescents in Canada, the cure rate has risen to more than 80% overall.

But the costs of cure are considerable, as measured by the financial impact on the family and adverse, late effects of treatment on the health of survivors.

Join Dr. Barr to hear about current research efforts to address refinements of the cancer therapy offered to children and how medical science continues to increase cure rates while minimising the burden of long-term morbidity in these young people.

This is a free public lecture.
All are welcome!


Wednesday September 19, 2007
Doors open at 6:30 p.m. Lecture begins at 7 p.m.
Hamilton Specator Auditorium
To reserve your seat:

e-mail
sciencecity@mcmaster.ca
Or by phone 905-525-9140, extension 24934

 

 

 

HEADER TEXT
 

Ronald D. Barr is a pediatric cancer specialist known locally, nationally and internationally for his work in the field of pediatric oncology, as co-author and author of seven books and more than 400 scientific articles. He received his medical degree from the University of Glasgow and is a fellow of the Royal College of Physicians (UK), the Royal College of Physicians and Surgeons of Canada, the Royal College of Paediatrics and Child Health, and the Royal College of Pathologists (Hematology).

Following his training in internal medicine and hematology Dr. Barr joined the Faculty of Medicine at the University of Nairobi as part of an arrangement with the UK government to establish the first medical school in Kenya. He joined the faculty of the University of Aberdeen before moving to the National Cancer Institute in Bethesda, MD as a visiting scientist.

Since 1977 he has been here at McMaster University as a professor of pediatrics in the Michael G. DeGroote School of Medicine, and chief of hematology-oncology at McMaster Children's Hospital.

Dr. Barr¹s main professional interests are international health, particularly cancer in childhood; late effects of cancer treatment, especially on nutritional status; and measurement of health-status and health-related quality of life (as a co-developer of the Health Utilities Index).

Barr is one of the editors of the recently released and first definitive document on the incidence, survival and mortality of 15 to 29 year-olds. Funded by the National Cancer Institute (NCI) in the United States, this monograph was a co-operative venture between the Children's Oncology Group (all 17 pediatric oncology centres in Canada and more than 200 American institutions) and the SEER (Survival Epidemiology and End Results) program.

Barr is a member of the NCI and Lance Armstrong Foundation's new Progress Review Group whose sole purpose is identifying and prioritizing the scientific, medical and psychosocial barriers facing adolescent and young adult (AYA) cancer patients. They plan to develop strategies to better the odds for this age group.

 

 

 

 
 
 
Contact Us | Terms of Use & Privacy Policy